Status:
UNKNOWN
Multi-center Application of an AI System for Diagnosis of Cervical Lesions Based on Colposcopy Images
Lead Sponsor:
Fujian Maternity and Child Health Hospital
Conditions:
Artificial Intelligence
Colposcopy
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
The application of artificial intelligence in image recognition of cervical lesions diagnosis has become a research hotspot in recent years. The analysis and interpretation of colposcopy images play a...
Detailed Description
Based on previous studies and clinical practice, this study carried out a multi center application in Fujian Province, China. In this study, Fujian Maternity and Child Health Hospital and Mindong Hosp...
Eligibility Criteria
Inclusion
- Married woman
- Woman aged 18 and over
- Woman with an intact cervix
- Patients with abnormal results in cervical cancer screening
- Be able to understand this study and have signed a written informed consent
Exclusion
- Woman with acute reproductive tract inflammation
- History of pelvic radiotherapy surgery
- Woman with mental disorder
- Patients with history of other malignant tumors
- Refuse to participate in this study
Key Trial Info
Start Date :
August 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2024
Estimated Enrollment :
10000 Patients enrolled
Trial Details
Trial ID
NCT05281939
Start Date
August 1 2021
End Date
September 1 2024
Last Update
November 18 2023
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Fujian Maternity and Child Health Hospital
Fuzhou, Fujian, China, 350001
2
Mindong Hospital of Ningde City
Ningde, Fujian, China, 352000
3
Jianou Maternal and child Health Care Hospital
Nanping, China
4
Ningde Hospital affiliated to Ningde Normal University
Ningde, China